Literature DB >> 23458572

Polyplex exposure inhibits cell cycle, increases inflammatory response, and can cause protein expression without cell division.

Rebecca L Matz1, Blake Erickson, Sriram Vaidyanathan, Jolanta F Kukowska-Latallo, James R Baker, Bradford G Orr, Mark M Banaszak Holl.   

Abstract

We sought to evaluate the relationship between cell division and protein expression when using commercial poly(ethylenimine) (PEI)-based polyplexes. The membrane dye PKH26 was used to assess cell division, and cyan fluorescent protein (CFP) was used to monitor protein expression. When analyzed at the whole population level, a greater number of cells divided than expressed protein, regardless of the level of protein expression observed, giving apparent consistency with the hypothesis that protein expression requires cells to pass through mitosis in order for the transgene to overcome the nuclear membrane. However, when the polyplex-exposed population was evaluated for the amount of division in the protein-expressing subpopulation, it was observed that substantial amounts of expression had occurred in the absence of division. Indeed, in HeLa S3 cells, this represented the majority of expressing cells. Of interest, the doubling time for both cell lines was slowed by ~2-fold upon exposure to polyplexes. This change was not altered by the origin of the plasmid DNA (pDNA) transgene promoter (cytomegalovirus (CMV) or elongation factor-1 alpha (EF1α)). Gene expression arrays in polyplex-exposed HeLa S3 cells showed upregulation of cell cycle arrest genes and downregulation of genes related to mitosis. Chemokine, interleukin, and toll-like receptor genes were also upregulated, suggesting activation of proinflammatory pathways. In summary, we find evidence that a cell division-independent expression pathway exists, and that polyplex exposure slows cell division and increases inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458572      PMCID: PMC3637663          DOI: 10.1021/mp300470d

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  84 in total

1.  Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus.

Authors:  S Brunner; T Sauer; S Carotta; M Cotten; M Saltik; E Wagner
Journal:  Gene Ther       Date:  2000-03       Impact factor: 5.250

Review 2.  In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.

Authors:  Sandrine A L Audouy; Lou F M H de Leij; Dick Hoekstra; Grietje Molema
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

Review 3.  Tumor suppressors and oncogenes in cellular senescence.

Authors:  F Bringold; M Serrano
Journal:  Exp Gerontol       Date:  2000-05       Impact factor: 4.032

Review 4.  Rethinking synchronization of mammalian cells for cell cycle analysis.

Authors:  S Cooper
Journal:  Cell Mol Life Sci       Date:  2003-06       Impact factor: 9.261

Review 5.  Intracellular trafficking of nonviral vectors.

Authors:  L K Medina-Kauwe; J Xie; S Hamm-Alvarez
Journal:  Gene Ther       Date:  2005-12       Impact factor: 5.250

6.  Which mechanism for nuclear import of plasmid DNA complexed with polyethylenimine derivatives?

Authors:  Stéphanie Grosse; Guiti Thévenot; Michel Monsigny; Isabelle Fajac
Journal:  J Gene Med       Date:  2006-07       Impact factor: 4.565

Review 7.  Intracellular DNA recognition.

Authors:  Veit Hornung; Eicke Latz
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

8.  8 color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity.

Authors:  M Roederer; S De Rosa; R Gerstein; M Anderson; M Bigos; R Stovel; T Nozaki; D Parks; L Herzenberg; L Herzenberg
Journal:  Cytometry       Date:  1997-12-01

9.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

10.  Cellular and molecular barriers to gene transfer by a cationic lipid.

Authors:  J Zabner; A J Fasbender; T Moninger; K A Poellinger; M J Welsh
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

View more
  7 in total

1.  pMINERVA: A donor-acceptor system for the in vivo recombineering of scFv into IgG molecules.

Authors:  M Batonick; M M Kiss; E P Fuller; C M Magadan; E G Holland; Q Zhao; D Wang; B K Kay; M P Weiner
Journal:  J Immunol Methods       Date:  2016-02-03       Impact factor: 2.303

2.  Quantitative Measurement of Cationic Polymer Vector and Polymer-pDNA Polyplex Intercalation into the Cell Plasma Membrane.

Authors:  Sriram Vaidyanathan; Kevin B Anderson; Rachel L Merzel; Binyamin Jacobovitz; Milan P Kaushik; Christina N Kelly; Mallory A van Dongen; Casey A Dougherty; Bradford G Orr; Mark M Banaszak Holl
Journal:  ACS Nano       Date:  2015-05-14       Impact factor: 15.881

3.  Opposing influence of intracellular and membrane thiols on the toxicity of reducible polycations.

Authors:  Chao Wu; Jing Li; Yu Zhu; Jun Chen; David Oupický
Journal:  Biomaterials       Date:  2013-08-12       Impact factor: 12.479

Review 4.  Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery.

Authors:  Hannah J Vaughan; Jordan J Green; Stephany Y Tzeng
Journal:  Adv Mater       Date:  2019-06-20       Impact factor: 30.849

Review 5.  Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy.

Authors:  Andrea L J Marschall
Journal:  BioDrugs       Date:  2021-10-27       Impact factor: 5.807

6.  A facile methodology using quantum dot multiplex labels for tracking co-transfection.

Authors:  Jessica A Kretzmann; RuiLu Feng; Alaa M Munshi; Diwei Ho; Anna M Ranieri; Massimiliano Massi; Martin Saunders; Marck Norret; K Swaminathan Iyer; Cameron W Evans
Journal:  RSC Adv       Date:  2019-06-27       Impact factor: 3.361

Review 7.  Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers.

Authors:  Mikhail Durymanov; Joshua Reineke
Journal:  Front Pharmacol       Date:  2018-08-21       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.